Exam 3 2025

Question 1

What drug is associated with purple toe syndrome

Answer 1

a) Warfarin

Question 2

What drug has an unique adverse drug reaction causing dyspnea?

Answer 2

Ticagrelor

Question 3

Which one causes flushing?
a) Amlodipine
b) ___
c) Niacin
d) All of the above

Answer 3

d) All of the above

Question 4

High dose statin

Answer 4

Atorvastatin 40-80mg

Question 5

What is an antiplatelet drug that doesn’t inhibit ADP binding at P2Y12 receptor?
a) Vorapaxar
b) Dabigatran

Answer 5

a) Vorapaxar

Question 6

Ticagrelor does

Answer 6

Inhibit ADP activation to P2Y12 receptor

Question 7

Injection site reaction
a) Inclisiran
b) Gemfibrozil
c) Aricomucab
d) A and C
e) All of the above

Answer 7

d) A and C

Question 8

Which of the following drugs block transport protein NPC1L1?

Answer 8

Ezetimibe

Question 9

What causes angioedema

Answer 9

a) __sartan

Question 10

Patient confirmed to have thromboembolic disease. What group ?

Answer 10

Group 4

Question 11

Nonproductive dry cough?

Answer 11

Ace inhibitors

Question 12

12) Statin adverse effects
a) Hepatotoxicity
b) Myopathy
c) Onset diabetes
d) All of the above

Answer 12

d) All of the above

Question 13

CCB (nifedipine), biggest dental complication
a) Xerostomia
b) Gingival Hyperplasia
c) Excessive Bleeding
d) Cough

Answer 13

b) Gingival Hyperplasia

Question 14

Epoprostenol Platelet inhibition dental complication
a) Bleeding
b) Delayed wound healing

Answer 14

a) Bleeding

Question 15

15) Which of the following factors does warfarin inhibit
a) 2
b) 8
c) 10
d) A and C

Answer 15

d) A and C

Question 16

Which drug is an endothelial receptor blocker
a) Ambresentan
b) selexipag

Answer 16

a) Ambresentan

Question 17

What drug causes hyperuricemia
a) Bempedoic acid
b) Niacin
c) A&B

Answer 17

c) A&B

Question 18

What drug is contraindicated with statin to cause myopathy

Answer 18

Fibrates

Question 19

What atherogenesis stage is associated with HDL reverse cholesterol transport

Answer 19

All of the above

Question 20

Man is 44yo and a non smoker. Has hypertension and diabetes mellitus. According to
the ASCVD risk score, how many risk factors does he have

Answer 20

2

Question 21

MOA of hydralazine

Answer 21

Interference of action of IP3

Question 22

RAAS:
a) ANG 1 to ANG 2
b) Renin to ANG1
c) ANG 2 to ANG 1

Answer 22

a) ANG 1 to ANG 2

Question 23

Which one is steroidoil mineralcorticoid receptor?
a) Spironolactone
b) Epenerone
c) Fineronne
d) A&B
e) All of the above

Answer 23

d) A&B

Question 24

Step in vasodilation:

Answer 24

a) Decrease in Ca+ due to guanylyl cyclase to increase cGMP

Question 25

Riociguoat:

Answer 25

a) Soluble guanyl cyclase simulator

Question 26

What medications would you want to raise patient because youre worried about gastrointestinal issues a) Cole (BABA) b) Evinacumab c) Evocumab d) A and B

Answer 26

a) Cole (BABA)?

Question 27

Which drug donates NO?

Answer 27

Nitroprusside

Question 28

Pleiotropic effects of statins a) Increased neovascularization of ischemic tissue b) Reduced platelet aggregability c) Improved endothelial function d) All of the above

Answer 28

d) All of the above

Question 29

Virchow’s triad

Answer 29

Vessel wall injury, blood stasis, hypercoagulability

Question 30

Lipoprotein moves TG to intestine to other parts

Answer 30

Chylomicrons

Question 31

Adverse reaction to aspirin a) Angioedema b) Tinnitus c) Rash d) All of the above

Answer 31

d) All of the above

Question 32

LMWH: enoxaparin

Answer 32

Do not require monitor of coagulation parameters

Question 33

Xa inhibitor

Answer 33

a) Do not require monitor of coagulation parameters

Question 34

Which drugs do you take orally a) Riociguat b) Selexipag c) Slidenafil d) All of the above

Answer 34

d) All of the above

Question 35

Which antiplatelet med works through inhibition of ADP binding at the P2Y12 Receptor?

Answer 35

Prasurgel (Effient)

Question 36

Dual antiplatelet therapy

Answer 36

a) Most dental procedures do not require you to stop antiplatelet therapy

Question 37

PCSK-9 inhibitor

Answer 37

Alirocumab

Question 38

Glycoprotein IIb/IIIa drug

Answer 38

Eptifibatide

Question 39

What is the mechanism of action of ___ acid

Answer 39

a) Competitive inhibition of plasminogen activation by binding to plasminogen

Question 40

What describes platelet function?

Answer 40

a) Clot formation due to adhesion, activation and aggregation

Question 41

Function of anti-fibrinolytic?

Answer 41

a) Inhibits plasminogen activation

Question 42

What inhibits Factor Xa? a) LMHWH b) DIRECT FACTOR XA INHIBITOR (apixiban and rivaroxiban) c) ___ d) ALL OF THE ABOVE

Answer 42

d) ALL OF THE ABOVE

Question 43

ACE inhibitors dental implication

Answer 43

a) Orthostatic hypotension